|
CIOMS
PUBLICATIONS
CIOMS publications that are currently in print are listed
below. To order publications please fill in the details of
the Publications Order form. Please note, prepayment is
not required, an invoice for payment will accompany the
order. Unfortunately CIOMS is unable to accept payment by credit card.
Payment is either by cheque or bank transfer. Full details of our
accepted payment methods are printed on our invoice.
Any enquiries on CIOMS publications may be directed to:
E-mail: cioms@who.int
Tel. +41 22 791 3413
Fax. +41 22 791 4286
AVAILABLE PUBLICATIONS
BIOETHICS AND HEALTH POLICY
Human Experimentation and Medical Ethics
Z. Bankowski & N. Howard-Jones, Eds.
1982. ISBN 92 9036 009 7. Sw.fr. 30.
Principles of Medical Ethics Relevant to the Protection
of Prisoners against Torture
Z. Bankowski, Ed.
1984. ISBN 92 9036 015 1. Sw.fr. 4.
Biomedical Research Involving Animals: Proposed
International Guiding Principles
Z. Bankowski & N. Howard-Jones, Eds.
1985. ISBN 92 9036 017 8. Sw.fr. 25.
Health Policy, Ethics and Human Values: An International
Dialogue
Z. Bankowski & J.H. Bryant, Eds.
1985. ISBN 92 9036 023 2. Sw.fr. 25.
International Guiding Principles for Biomedical Research
Involving Animals
Z. Bankowski & N. Howard-Jones, Eds.
1986. ISBN 92 9036 019 4. Sw.fr. 4.
Health Manpower out of Balance: Conflicts and
Prospects
Z. Bankowski & A. Mejia, Eds.
1987. ISBN 92 9036 030 5. Sw.fr. 20.
Ethics and Research on Human Subjects: International
Guidelines
Z. Bankowski & R.J. Levine, Eds.
1992. ISBN 92 9036 054 2. Sw.fr. 25.
Ethics, Equity and Health for All
Z. Bankowski, J.H. Bryant & J. Gallagher, Eds.
1997. ISBN 92 9036 066 6. Sw.fr. 20.
Biomedical Research Ethics: Updating International
Guidelines - A Consultation
R.J. Levine & S. Gorovitz, Eds. with J.
Gallagher
2000. ISBN 92 9036 073 9. Sw.fr. 30.
International Ethical Guidelines for Biomedical Research
Involving Human Subjects
Translations only available in
Ch/Fr/Port//Sp/Viet
International Ethical Guidelines for Epidemiological Studies
(Updated Edition)
2009. ISBN 92 9036 081 X. Sw.fr. 45.
DRUG DEVELOPMENT AND USE
Definition and
Application of Terms for Vaccine Pharmacovigilance
(Report of CIOMS/WHO Working Group on Vaccine Pharmacovigilance)
2011.ISBN 978 92 9036 083 4
Price: Swiss francs CHF 35.00/US$ 42.00
In developing countries: CHF 24.50/US$ 29.40
Safety Requirements for the First Use of New Drugs and
Diagnostic Agents in Man
C.D. Dollery & Z. Bankowski, Eds.
1983. ISBN 92 9036 012 5. Sw.fr. 15.
Current Challenges in Pharmacovigilance: Pragmatic
Approaches
(Report of CIOMS Working Group V)
2001. ISBN 92 9036 074 7. Sw.fr. 30.
Development and Rational Use of
Standardised MedDRA Queries (SMQs)
Retrieving Adverse Drug Reactions with MedDRA
(Report of the CIOMS Working Group)
2004. ISBN 92 9036 077 1. Sw.fr. 25.
Management of Safety Information from Clinical
Trials
(Report of CIOMS Working Group VI)
2005. ISBN 92 9036 079 8. Sw.fr. 40.
The Development Safety update report (DSUR):
Harmonizing the format and content of periodic Safety
Reporting During Clinical Trials
(Report of CIOMS Working Group VII published by CIOMS
Geneva)
2006. ISBN 92 9036 080 1. Sw.fr. 35.
Practical Aspects of Signal Detection in Pharmacovigilance
(Report of CIOMS Working Group VIII)
2010. ISBN 92 9036 082 8. Sw.fr 39.
INTERNATIONAL NOMENCLATURE OF DISEASES
Infectious Diseases, Volume II,
Part 1: Bacterial Diseases
1984. ISBN 92 9036 022 4. Sw.fr. 20.
Infectious Diseases, Volume II,
Part 2: Mycoses
1982. ISBN 92 9036 007 0. Sw.fr. 15.
Infectious Diseases, Volume II,
Part 3: Viral Diseases
1983. ISBN 92 9036 011 9. Sw.fr. 20.
Infectious Diseases, Volume II,
Part 4: Parasitic Diseases
1988 ISBN 92 9036 032 1. Sw.fr. 20.
Diseases of the Lower Respiratory Tract, Volume III
1979. ISBN 92 9036 001 1
Out of print
Diseases of the Digestive System, Volume IV
1990, ISBN 92 9036 041 0. Sw.fr. 20.
Cardiac and Vascular Diseases, Volume V
1989. ISBN 92 9036 037 2. Sw.fr. 20.
Metabolic, Nutritional and Endocrine Disorders, Volume
VI
1990. ISBN 92 9036 045 3. Sw.fr. 25.
Diseases of the Kidney, the Lower Urinary Tract and the
Male Genital System, Volume VII
1991. ISBN 92 9036 050 X
Diseases of the Female Genital System, Volume VIII
1992. ISBN 92 9036 044 5
Out of print
SERIES OF PAPERS ON BASIC REQUIREMENTS FOR THE
USE OF TERMS FOR REPORTING ADVERSE DRUG REACTIONS
1. International Reporting on Adverse Drug Reactions:
the CIOMS Project. International Journal of Clinical
Pharmacology, Therapy and Toxicology, 1990;28(4):
133-138
2. Standardization of definitions and criteria of causality
assessment of adverse drug reactions. Drug-induced liver
disorders: Report of an International Consensus
Meeting. International Journal of Clinical Pharmacology,
Therapy and Toxicology, 1990;(28(8): 317-322
3. Standardization of definitions and criteria of causality
assessment of adverse drug reactions. Drug-induced
cytopenia. International Journal of Clinical Pharmacology,
Therapy and Toxicology, 1991;29(2): 75-81)
4. Basic Requirements for the Use of Terms for Reporting
Adverse Drug Reactions. Key words: Anaphylactic shock,
arrhythmia, cardiac failure, hypertension, thrombosis and
embolism. Pharmacoepidemiolgy and Drug Safety, 1992; 1:
39-45
5. Basic Requirements for the Use of Terms for Reporting
Adverse Drug Reactions (II). Key words: Colitis,
gastrointestinal haemorrhage, hepatocelular damage, peptic
ulcer, pancreatitis. Pharmacoepidemiology and Drug
Safety, 1992; 1: 133-137
6. Basic Requirements for the Use of Terms for Reporting
Adverse Drug Reactions (III). Key words: Aplastic
anaemia, bone marrow depression, coagulation disorders,
agranulocytosis, thrombophlebitis. Pharmacoepidemiology and
Drug Safety, 1992; 1: 191-196
7. Basic Requirements for the Use of Terms for Reporting
Adverse Drug Reactions (IV). Key words: Dyskinesia,
depression, myopathy, neuropathy, paralysis, convulsions.
Pharmacoepidemiology and Drug Safety, 1993; 2:
149-153
8. Basic Requirements for the Use of Terms for Reporting
Adverse Drug Reactions (V). Key words: Vision abnormal,
keratitis, cataract, retinal disorder acidosis.
Pharmacoepidemiology and Drug Safety, 1994; 2:
189-193
9. Definition of Adverse Drug Reactions and Minimum
Requirements for Their Use - Cardiovascular Disease Terms.
Key words: Heart malformation, artery malformation,
aortic coarctation, atrial septal defect, pulmonic stenosis
congenital, aortic stenosis, mitral insufficiency,
pericarditis, pericardial effusion, haemopericardium,
endocarditis, myocarditis, arteriosclerosis,
artherosclerosis, angina pectoris, myocardial ischaemia,
myocardial infarction, coronary artery disorder, thrombosis
coronary, cardiac aneurysm, mycocardial rupture (post
infarct), cardiomyopathy, fibrosis endoymyocardial.
Pharmacoepidemiology and Drug Safety, 1993; 2:
591-602
10. Harmonizing the Use of Adverse Drug Reaction Terms.
Definitions of Terms and Minimum Requirements for Their Use:
Respiratory Disorders and Skin Disorders. Key words:
Apnoea, asphyxia, asthma, bradypnoea,
bronchoconstriction, chronic obstructive pulmonary disease,
dyspnoea, hypercapnia, hypoventilation, hypoxia,
interstitial lung disease, pneumonitis, pulmonary fibrosis,
pulmonary oedema, respiratory arrest, respiratory
depression, respiratory distress syndrome acute (ARDS),
respiratory paralysis. Pharmacoepidemiology and Drug Safety,
1997;6: 115-127
11. Basic Requirements for the Use of Terms for Reporting
Adverse Drug Reactions (VIII): Renal and Urinary System
Disorders. Key words: glomerular vasomotor disorder,
glomerulonephritis, nephritis interstitial: acute and
chronic, nephropathy toxic, nephrotic syndrome, renal
failure, renal failure (intrinsic) acute, renal tubular
disorder, renal vasculitis, urinary retention.
Pharmacoepidemiology and Drug Safty, 1997; 6:
203-211
12. Definitions and Terms for Reporting Adverse Drug
Reactions (IX): Nervous System and Psychiatric Disorders.
Key words: Central and peripheral nervous system terms:
anticholinergic syndrome, choreoathetosis, dysphonia,
dystonia, encephalopathy, extrapyramidal disorder, gait
abnormal, hypertonia, hypotonia, neuroleptic malignant
syndrome, oculogyric crisis, serotonin syndrome, speech
disorder. Psychiatric disorder terms: anorexia, apathy,
delirium, depersonalization, personality disorder,
psychosis, thinking abnormal. Pharmacoepidemiology and Drug
Safety, 1998; 7: 39-49
13. Definitions and Basic Requirements for the Use of Terms
for Reporting Adverse Drug Reactions (X): Gastrointestinal
System Disorders. Key words: Abdominal pain, colitis
collagenous, constipation, diarrhoea, dyspepsia, gastritis,
gastrointestinal infarction/necrosis/gangrene, haematemesis,
haematochezia, ileus, intestinal ischaemia, intestinal
obstruction, intestinal perforation, intestinal stenosis,
melena, oesophageal ulcer, peritonitis, stomatitis,
stomatitis ulcerative, ulcer oesophago-gastro-intestinal, or
ulcer of the alimentary tract. Pharmacoepidemiology and Drug
Safety, 1998; 7: 281-287
14. Definitions and Basic Requirements for the Use of Terms
for Reporting Adverse Drug Reactions (XI): Cardiovascular
System Disorders. Key words: Arterial occlusive disease,
hypotension, hypotension postural, hypertension pulmonary,
syncope, circulatory failure, shock, arrhythmia ventricular,
fibrillation atrial, fibrillation ventricular, AV block,
cardiac arrest, palpitation, torsade de pointes, cerebral
infarction, cerebral haemorrhage, cerebrovascular disorders,
haemorrhage intracranial. Pharmacoepidemiology and Drug
Safety, 1998; 7: 351-357
15. Definitions and Basic Requirements for the Use of Terms
for Reporting Adverse Drug Reactions (XII): Collogen
Disorders and Musculo-Skeletal Disorders. Key words:
Fracture pathological; lupus erythematosus syndrome:
myositis; osteporosis; retroperitoneal fibrosis; vasculitis.
Pharmacoepidemology and Drug Safety, 1999; 8:
141-145
16. Definitions and Basic Requirements for the Use of Terms
for Reporting Adverse Drug Reactions (XIII): Clinical
Pathology and General Disorders. Key words:
Aggravated/exacerbated; anaemia aplastic: anaemia
haemolytic: anaemia hypochromic mycrocytic; anaphylactic
reaction; anaphylactic shock; anaphylactoid reaction;
asthenia; dehydration; gout; hypovolaemia; malaise;
ototoxicity; pancytopenia; rigors; withdrawal syndrome.
Pharmacoepidemology and Drug Safety, 1999; 8:
217-224
|